Ongoing research has identified multiple infectious diseases that may play a role in the development of neuropsychiatric disorders, particularly in people predisposed to genetic and environmental factors.
Central nervous system effects of clarithromycin, beta-lactams, and fluoroquinolones occur because of their GABA-A antagonist action.
Eating disorders (ED) are associated with significant comorbid psychopathology and the most extensive medical complications of any psychiatric disorder.
Avoidant restrictive food intake disorder, or ARFID, is a newly introduced eating disorder in DSM-5. Given that the disorder was introduced in 2013, it remains unclear how prevalent ARFID is in the general population.
This article describes a model for anorexia nervosa that is useful when working with patients or families to help them understand the complexity of the illness.
Treating eating disorders can feel challenging because patients are typically ambivalent about changing their behavior; however, it is also rewarding, as full recovery is possible even in the most chronically and severely ill patients.
Eating disorders (EDs) are associated with high medical and psychiatric comorbidity, poor quality of life, and high mortality, and mortality from anorexia nervosa (AN) is the highest of all mental disorders. Fortunately, there are a number of evidence-based psychological treatment approaches for EDs.
Anorexia nervosa (AN) is a severe and debilitating illness with one of the highest mortality rates of any psychiatric disorder. The illness course is often long, recovery is slow, and the rates of full recovery are low.
More than two-thirds of patients with eating disorders also have comorbid mood and anxiety disorders. This article considers how a transdiagnostic process called interoception may help to advance our understanding and treatment of eating disorders.
While the core features of autism impair functioning, a significant source of further impairment is comorbid psychiatric disorders.